tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
US Market
Advertisement

Immunovant (IMVT) Ownership - Who Owns Immunovant?

Compare
871 Followers

Immunovant (IMVT) Ownership Overview

59.46%14.05%0.08%7.15%19.26%
59.46% Insiders
0.08% Other Institutional Investors
7.15% ETFs
19.26% Public Companies and Individual Investors
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 21.28% of the company’s stock is owned by Institutional Investors, 59.46% is owned by Insiders, and 19.26% is owned by Public Companies and Individual Investors.
The ownership structure of Immunovant (IMVT) stock is a mix of institutional, retail, and individual investors. Approximately 14.13% of the company’s stock is owned by Institutional Investors, 59.46% is owned by Insiders, and 7.15% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 25, 2025
xxxxxxxxxxxxx
$43288
Jul 25, 2025
xxxxxxxxxxxxx
$50911
Jul 11, 2025
xxxxxxxxxxxxx
$19998
Jul 11, 2025
xxxxxxxxxxxxx
$26188

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$3131632
Jun 30, 2025
xxxxxxxxxxxxx
$23979600
Jun 30, 2025
xxxxxxxxxxxxx
$34206240

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
96,650,341Insider55.45%1,474,884,204
7,394,663Institution4.24%112,842,557
6,352,328Institution3.64%96,936,525
6,098,562Institution3.50%93,064,056
5,457,881Institution3.13%83,287,264
3,092,290Institution1.77%47,188,345
2,405,345Institution1.38%36,705,565
2,137,890Institution1.23%32,624,201
1,498,725Institution0.86%22,870,544
1,476,594Institution0.85%22,532,824

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
7,394,663Institution4.24%112,842,557
6,098,562Institution3.50%93,064,056
2,405,345Institution1.38%36,705,565
1,285,933Institution0.74%19,623,338
1,176,064Institution0.67%17,946,737
825,221Institution0.47%12,592,872
642,615Institution0.37%9,806,305
639,576Institution0.37%9,759,930
599,050Institution0.34%9,141,503
564,699Institution0.32%8,617,307

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,126,637Institution1.22%34,196,323
1,662,957Institution0.95%26,740,349
1,604,430Institution0.92%24,483,602
1,337,644Institution0.77%20,358,942
1,072,222Institution0.62%17,241,330
828,549Institution0.48%13,323,068
607,048Institution0.35%9,263,552
424,399Institution0.24%6,476,329
361,466Institution0.21%5,501,513
325,750Institution0.19%5,238,060

FAQ

Who Owns Immunovant (IMVT)?
According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 59.46% is held by insiders, and 19.26% is held by retail investors.
    What percentage of Immunovant (IMVT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.08% of Immunovant (IMVT) stock is held by institutional investors.
      What percentage of Immunovant (IMVT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 19.26% of Immunovant (IMVT) stock is held by retail investors.
        Who owns the most shares of Immunovant (IMVT)?
        Roivant Sciences Ltd. owns the most shares of Immunovant (IMVT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis